Synthetic Immunotherapeutics against Gram-negative Pathogens.

Area of Science:

• Microbiology
• Immunology
• Drug Discovery

Background:

• Traditional antibiotic discovery faces challenges, necessitating alternative strategies.
• Gram-negative pathogens like Escherichia coli and Pseudomonas aeruginosa are significant threats.
• Polymyxin B is an antibiotic that binds to the surface of Gram-negative bacteria.

Purpose of the Study:

• To design and evaluate novel antimicrobial agents that recruit the host immune system.
• To create conjugates linking polymyxin B with antigenic epitopes to target bacterial surfaces.
• To investigate the role of spacer length in conjugate efficacy.

Main Methods:

• Conjugates were synthesized by linking polymyxin B to antigenic epitopes.
• Bacterial surface display and efficacy were assessed experimentally.
• Molecular dynamics simulations were used to study hapten display.
• Bacterial killing assays were performed in the presence of human serum.

Main Results:

• Spacer length significantly influenced hapten display on the bacterial cell surface.
• Experimental and simulation data confirmed the role of spacer length.
• The designed agents demonstrated specific killing of bacteria with human serum.
• The conjugates effectively re-engaged the immune system against target pathogens.

Conclusions:

• Novel antimicrobial agents can be designed by decorating bacterial cell surfaces.
• These agents harness the host immune system for bacterial killing.
• The findings suggest a promising new antimicrobial modality for Gram-negative infections.